Labcorp appoints dr. paul rothman to board of directors

Health system executive brings three decades of medical enterprise experience to labcorp burlington, n.c. , june 7, 2023 /prnewswire/ -- labcorp (nyse: lh), a leading global life sciences company, today announced the appointment of dr. paul rothman to its board of directors as an independent member.
LH Ratings Summary
LH Quant Ranking